Log in

Xenon Pharmaceuticals SEC Filings & 10K Form (NASDAQ:XENE)

$16.29
-0.42 (-2.51 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$15.92
Now: $16.29
$16.93
50-Day Range
$13.25
MA: $15.78
$17.57
52-Week Range
$7.58
Now: $16.29
$18.45
Volume199,894 shs
Average Volume251,812 shs
Market Capitalization$421.42 million
P/E RatioN/A
Dividend YieldN/A
Beta1.5

SEC Filings

Xenon Pharmaceuticals (NASDAQ:XENE) SEC Filings

DateFilerForm TypeView
02/14/2020
2:29 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G/A
01/23/2020
3:44 PM
Xenon Pharmaceuticals (Filer)
Form 424B5
01/23/2020
3:38 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2020
3:11 PM
Xenon Pharmaceuticals (Filer)
Form 424B5
01/14/2020
1:34 PM
Desjardins Clarissa (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
1:24 PM
Desjardins Clarissa (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2020
7:15 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
5:08 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
4:04 PM
AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
3:14 PM
NEUROCRINE BIOSCIENCES INC (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13D
12/06/2019
4:12 PM
PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
6:52 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
12:30 PM
TARNOW MICHAEL M (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
4:16 PM
Xenon Pharmaceuticals (Filer)
Form 424B5
11/05/2019
3:54 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
3:48 PM
Xenon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
3:45 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
5:14 PM
PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
3:15 PM
HOLLER FRANK A (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
6:45 PM
TARNOW MICHAEL M (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
6:44 PM
Svoronos Dawn (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
6:41 PM
ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
6:39 PM
SCHELLER RICHARD H (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
6:06 PM
PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:51 PM
PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:47 PM
MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:43 PM
HOLLER FRANK A (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:35 PM
Hayden Michael R (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:33 PM
GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:28 PM
EMPFIELD JAMES R. (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:21 PM
AYCARDI-FONSECA ERNESTO (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
3:46 PM
AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
7:13 PM
HOLLER FRANK A (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
5:58 PM
ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
3:34 PM
Xenon Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/11/2019
3:38 PM
Xenon Pharmaceuticals (Filer)
Form CT ORDER
09/11/2019
3:33 PM
Xenon Pharmaceuticals (Filer)
Form CT ORDER
09/10/2019
3:51 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2019
11:15 PM
Xenon Pharmaceuticals (Filer)
Form EFFECT
08/06/2019
3:58 PM
Xenon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2019
3:44 PM
Xenon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:39 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
7:41 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
10:56 AM
TARNOW MICHAEL M (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
3:45 PM
Xenon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:40 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
3:30 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
4:13 PM
Hayden Michael R (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
4:16 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
4:00 PM
Hayden Michael R (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
4:06 PM
Xenon Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2019
3:45 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:19 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
2:39 PM
Vivo Opportunity, LLC (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
7:37 AM
venBio Select Advisor LLC (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G
02/13/2019
1:09 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G/A
12/26/2018
10:00 AM
TARNOW MICHAEL M (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
3:06 PM
PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
1:06 PM
Xenon Pharmaceuticals (Filer)
Form CT ORDER
12/13/2018
12:56 PM
COHEN CHARLES J. (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
8:10 PM
AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
3:42 PM
Xenon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
3:09 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2018
3:28 PM
Xenon Pharmaceuticals (Filer)
Form 424B5
09/13/2018
3:25 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2018
3:09 PM
Xenon Pharmaceuticals (Filer)
Form 424B5
09/12/2018
3:02 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2018
2:27 PM
Xenon Pharmaceuticals (Filer)
Form CT ORDER
09/10/2018
8:29 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2018
7:14 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2018
7:34 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
12:01 PM
Capital World Investors (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G/A
08/07/2018
4:02 PM
Xenon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
3:51 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2018
5:05 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2018
8:59 PM
Xenon Pharmaceuticals (Filer)
Form 424B5
07/03/2018
2:35 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
11:56 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G
06/22/2018
3:40 PM
TARNOW MICHAEL M (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
3:39 PM
AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
6:32 PM
PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
7:36 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2018
12:33 PM
Capital World Investors (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G/A
06/05/2018
3:42 PM
TARNOW MICHAEL M (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:41 PM
Svoronos Dawn (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:41 PM
SCHELLER RICHARD H (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:41 PM
PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:40 PM
HOLLER FRANK A (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:40 PM
Hayden Michael R (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:39 PM
GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:39 PM
AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:13 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
6:23 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
4:00 PM
Xenon Pharmaceuticals (Filer)
Form 424B5
05/08/2018
3:55 PM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
3:47 PM
Xenon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/29/2018
5:37 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
4:12 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Xenon Pharmaceuticals (Subject)
Form SC 13G/A
03/28/2018
7:50 AM
Xenon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2018
3:44 PM
AYCARDI-FONSECA ERNESTO (Reporting)
Xenon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel